Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of atopic dermatitis
3.2.1.2 Growing investments for research and development activities
3.2.1.3 Increasing pipeline products for atopic dermatitis
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with clinical trials
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Molecule Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Large molecules
5.3 Small molecules
Chapter 6 Market Estimates and Forecast, By Study Design, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Interventional study
6.3 Observational study
6.4 Expanded access study
Chapter 7 Market Estimates and Forecast, By Phase, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Phase I
7.3 Phase II
7.4 Phase III
7.5 Phase IV
Chapter 8 Market Estimates and Forecast, By Mode, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Outsourced
8.3 In-house
Chapter 9 Market Estimates and Forecast, By Industry, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Contract research organizations
9.3 Pharmaceutical and biotechnology companies
9.4 Research and academic institutes
Chapter 10 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 BIOCYTOGEN
11.2 Charles River Laboratories
11.3 Hooke Laboratories, LLC
11.4 Imavita
11.5 Novotech
11.6 Oncodesign services
11.7 QIMA LTD
11.8 Redoxis
11.9 REPROCELL Inc.
11.10 Syneos Health
